Literature DB >> 11007940

Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells.

I Rahman1.   

Abstract

The development of an oxidant/antioxidant imbalance in lung inflammation may activate redox-sensitive transcription factors such as nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1), which regulate the genes for proinflammatory mediators and protective antioxidant genes. GSH, a ubiquitous tripeptide thiol, is a vital intra- and extracellular protective antioxidant against oxidative stress, which plays a key role in the control of proinflammatory processes in the lungs. The rate-limiting enzyme in GSH synthesis is gamma-glutamylcysteine synthetase (gamma-GCS), which consists of a catalytic heavy and a regulatory light subunit. The promoter regions of the human gamma-GCS subunits contain AP-1, NF-kappa B, and antioxidant response elements and are regulated by oxidants, growth factors, inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha), and anti-inflammatory agent (dexamethasone) in lung cells. TNF-alpha depletes intracellular GSH, concomitant with an increase in oxidised glutathione levels in alveolar epithelial cells. TNF-alpha also induces the activation of NF-kappa B and AP-1 and the subsequent increase in gamma-GCS heavy subunit transcription in these cells. Dexamethasone depleted both basal and TNF-alpha-stimulated GSH levels by down-regulating the gamma-GCS-heavy subunit transcription via a mechanism involving AP-1 (c-Jun). The existence of this fine tuning between the redox GSH levels and the activation of transcription factors may determine the balance of transcription for proinflammatory and antioxidant gamma-GCS genes in inflammation. More studies are required to understand the signalling mechanism of the redox regulation of NF-kappa B and AP-1 and gene transcription in inflammation. This could lead to the development of therapeutic strategies based on the pharmacological manipulation of the production of this important antioxidant in inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007940     DOI: 10.1016/s0006-2952(00)00392-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  27 in total

1.  Antioxidant supplementation reduces endometriosis-related pelvic pain in humans.

Authors:  Nalini Santanam; Nino Kavtaradze; Ana Murphy; Celia Dominguez; Sampath Parthasarathy
Journal:  Transl Res       Date:  2012-05-31       Impact factor: 7.012

2.  Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis.

Authors:  J J Haddad; S C Land
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic.

Authors:  J D Uys; Y Manevich; L C Devane; L He; T E Garret; C J Pazoles; K D Tew; D M Townsend
Journal:  Biomed Pharmacother       Date:  2010-02-24       Impact factor: 6.529

4.  Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation.

Authors:  Irfan Rahman; Peter S Gilmour; Luis Albert Jimenez; William MacNee
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

5.  Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells.

Authors:  Hongqiao Zhang; Albert Shih; Alessandra Rinna; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2008-10-22       Impact factor: 4.013

6.  Activator protein-1 activation in acute lung injury.

Authors:  Ren-Feng Guo; Alex B Lentsch; J Vidya Sarma; Lei Sun; Niels C Riedemann; Shannon D McClintock; Stephanie R McGuire; Nico Van Rooijen; Peter A Ward
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

7.  Interleukin 1β and tumor necrosis factor α promote hFOB1.19 cell viability via activating AP1.

Authors:  Hongliang Ying; Qiang Li; Changfu Zhao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 8.  Effects of nanomaterial physicochemical properties on in vivo toxicity.

Authors:  Kristin L Aillon; Yumei Xie; Nashwa El-Gendy; Cory J Berkland; M Laird Forrest
Journal:  Adv Drug Deliv Rev       Date:  2009-04-20       Impact factor: 15.470

9.  Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Toxicol Ind Health       Date:  2009 May-Jun       Impact factor: 2.273

10.  The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species.

Authors:  Darren C Phillips; Kevin J Woollard; Helen R Griffiths
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.